Lambert, N., Ly, J., Deprez, L., & WILLEMS, E. (2023). Hemispheric Hypoperfusion in Immune Effector Cell-Associated Neurotoxicity Syndrome following Chimeric Antigen Receptor T-Cell Therapy. Annals of Neurology. doi:10.1002/ana.26832 |
Plumacker, F., Lambert, N., & Maquet, P. (August 2023). Immune-mediated cerebellitis following SARS-CoV-2 infection-a case report and review of the literature. Journal of Neurovirology, 29 (4), 507 - 518. doi:10.1007/s13365-023-01163-x |
Boumaza, X., Bonneau, B., Roos-Weil, D., Pinnetti, C., Rauer, S., Nitsch, L., Del Bello, A., Jelcic, I., Sühs, K.-W., Gasnault, J., Goreci, Y., Grauer, O., Gnanapavan, S., Wicklein, R., Lambert, N., Perpoint, T., Beudel, M., Clifford, D., Sommet, A., ... Immunotherapy for PML Study Group. (February 2023). Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors. Annals of Neurology, 93 (2), 257 - 270. doi:10.1002/ana.26512 |
El Moussaoui, M., Desmecht, S., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., Toussaint, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., GREGOIRE, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (2023). Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV. Viruses, 15, 1435. doi:10.3390/v15071435 |
Lambert, N., & Moïse, M. (January 2023). Acute necrosis of the corpus callosum. European Journal of Internal Medicine, 107, 95 - 96. doi:10.1016/j.ejim.2022.10.008 |
El Moussaoui, M., Desmecht, S., Tashkeev, A., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., TOUSSAINT, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., Grégoire, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (05 September 2022). Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIV. Journal of Infection, 85, 751-755. doi:10.1016/j.jinf.2022.09.006 |
El Moussaoui, M., Maes, N., Hong, S. L., Lambert, N., Gofflot, S., DELLOT, P., Belhadj, Y., Huynen, P., Hayette, M.-P., Meex, C., Bontems, S., Defêche, J., Godderis, L., Molenberghs, G., Meuris, C., Artesi, M., Durkin, K., Rahmouni, S., GREGOIRE, C., ... DARCIS, G. (14 June 2022). Evaluation of Screening Program and Phylogenetic Analysis of SARS-CoV-2 Infections among Hospital Healthcare Workers in Liège, Belgium. Viruses, 14 (6), 1302. doi:10.3390/v14061302 |
Lambert, N., El Moussaoui, M., Ritacco, C., MOISE, M., PAULUS, A., DELVENNE, P., BARON, F., SADZOT, B., & MAQUET, P. (03 May 2022). Killing Two Birds With One Stone: Effective Control of Both Non-Small Cell Lung Cancer and Progressive Multifocal Leukoencephalopathy With Atezolizumab, A Case Report. Frontiers in Immunology, 13, 889148. doi:10.3389/fimmu.2022.889148 |
Lambert, N., MOISE, M., & Nguyen, L. (2022). E3 Ubiquitin ligases and cerebral cortex development in health and disease. Developmental Neurobiology. doi:10.1002/dneu.22877 |
Lambert, N., LUTTERI, L., TSHIBANDA, L., BIANCHI, E., & MAQUET, P. (2022). Anti-SOX1 antibody-associated acute hemorrhagic leukoencephalitis. Journal of Neurology. doi:10.1007/s00415-022-10984-5 |
Lambert, N., Dauby, S., DIVE, D., SADZOT, B., & MAQUET, P. (January 2022). Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy. Emerging Infectious Diseases, 28 (1). doi:10.3201/eid2801.204809 |
El Moussaoui, M., Lambert, N., MAES, N., Fombellida, K., VAIRA, D., MOUTSCHEN, M., & DARCIS, G. (2021). Impact of the COVID-19 pandemic situation on HIV care in Liège, Belgium. HIV Research & Clinical Practice. doi:10.1080/25787489.2021.1948773 |
Lambert, N., El Moussaoui, M., & MAQUET, P. (2021). Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: identifying relevant outcome factors. European Journal of Neurology. doi:10.1111/ene.15021 |
Lambert, N., LUTTERI, L., SADZOT, B., MAQUET, P., & Moonen, G. (June 2021). Les syndromes neurologiques paranéoplasiques. Revue Médicale de Liège, 76 (5-6), 413-418. |
Lambert, N., Hansen, I., El Moussaoui, M., GIOT, J.-B., Vercheval, C., LOMMERS, E., SOMJA, J., MOUTSCHEN, M., & MAQUET, P. (2021). Lung and liver sarcoidosis‐like reaction induced by tocilizumab. British Journal of Clinical Pharmacology. doi:10.1111/bcp.14878 |
Lambert, N., Steinmetz, M., SIBILLE, A., & SADZOT, B. (2021). Pembrolizumab‐induced migrating cortico‐subcortical brain lesions. Annals of Neurology. doi:10.1002/ana.26054 |